Timothy M. Kish
Chief Executive Officer at BeCaid LLC
Profile
Timothy M.
Kish is the founder of Ren Pharmaceuticals, Inc. He is currently the Chief Executive Officer at BeCaid LLC and also holds a position as President & Chief Financial Officer at RHEI Pharmaceuticals, Inc. Previously, he worked as the Chief Financial Officer & Vice President at Biogen MA, Inc. from 1993 to 2000 and as the Chief Financial Officer at Illumina, Inc. He completed his undergraduate degree at Michigan State University and earned an MBA from the University of Minnesota.
Timothy M. Kish active positions
Companies | Position | Start |
---|---|---|
RHEI Pharmaceuticals, Inc.
RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RHEI Pharmaceuticals, Inc. acquires licenses, develops and commercializes therapies. The company was founded by Harry H. Penner, John W. Childs, Xin Sylvia He and Glenn A. Hopkins in 2008 and is headquartered in New Haven, CT. | Director of Finance/CFO | - |
BeCaid LLC
BeCaid LLC Miscellaneous Commercial ServicesCommercial Services BeCaid LLC is a scientifically-based cognitive cross training program shown to increase test scores. It designed by neuroscientists from Yale University, the program integrates web-based computer games and physical exercise, and strengthens core cognitive capacities such as attention, memory, and focus. . The company was founded by Bruce E. Wexlerin 2011 and is headquartered in New Haven, CT. | Chief Executive Officer | 28/02/2017 |
Former positions of Timothy M. Kish
Companies | Position | End |
---|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 03/01/2000 |
Ren Pharmaceuticals, Inc.
Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ren Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals closed a Series A financing in November 2006 with Sanderling Ventures, Venrock Associates and Amgen Ventures as investors. The company's R&D is currently located in South San Francisco, California. | Founder | - |
ILLUMINA, INC. | Director of Finance/CFO | - |
Training of Timothy M. Kish
Michigan State University | Undergraduate Degree |
University of Minnesota | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ILLUMINA, INC. | Health Technology |
Private companies | 4 |
---|---|
Ren Pharmaceuticals, Inc.
Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ren Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals closed a Series A financing in November 2006 with Sanderling Ventures, Venrock Associates and Amgen Ventures as investors. The company's R&D is currently located in South San Francisco, California. | Health Technology |
RHEI Pharmaceuticals, Inc.
RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RHEI Pharmaceuticals, Inc. acquires licenses, develops and commercializes therapies. The company was founded by Harry H. Penner, John W. Childs, Xin Sylvia He and Glenn A. Hopkins in 2008 and is headquartered in New Haven, CT. | Health Technology |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
BeCaid LLC
BeCaid LLC Miscellaneous Commercial ServicesCommercial Services BeCaid LLC is a scientifically-based cognitive cross training program shown to increase test scores. It designed by neuroscientists from Yale University, the program integrates web-based computer games and physical exercise, and strengthens core cognitive capacities such as attention, memory, and focus. . The company was founded by Bruce E. Wexlerin 2011 and is headquartered in New Haven, CT. | Commercial Services |
- Stock Market
- Insiders
- Timothy M. Kish